Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort

Nusinersen treatment initiated before 12 months of age, especially before 3 months of age, yielded the most favorable motor outcomes in patients with SMA type 1. Early initiation is associated with improved motor milestones and reduced need for ventilatory support. However, no significant improvements were observed in the bulbar function or in patients requiring extensive respiratory support.

Authors

Institutions

Publication Details

Journal
Frontiers in Neurology
Published
2025-03-27
DOI
https://doi.org/10.3389/fneur.2025.1541507
Citations
3
Primary Topic
Neurogenetic and Muscular Disorders Research
Type
article
Field-Weighted Citation Impact
4.88
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort

Gülhıs Deda, Kürşat Bora Çarman, Gökmen Zararsız, Özgür Duman et al.
3 citations
Frontiers in Neurology
Neurogenetic and Muscular Disorders Research
4.88
article

Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort

Gülhıs Deda, Kürşat Bora Çarman, Gökmen Zararsız, Özgür Duman, Uluç Yiş, Bülent Kara, Deniz Yüksel, Murat Gülşen, Sema Saltık, Mustafa Kömür, Aycan Ünalp, Didem Ardıçlı, Gülten Öztürk, Figen Baydan, Ömer Bektaş, Hüseyin Tan, Ahmet Sami Güven, Onur Burak Dursun, Bilge Özgör, Gökçen Öz-Tuncer, Edibe Pembegül Yıldız, Elif Acar Arslan, Arzu Ekici, Süleyman Şahin, Ayşe Aysima Özçelik, Ahmet Tekin, Mehmet Canpolat, Merve Feyza Yüksel, Aynur Ayşe Karaduman, Ercan Demir, Seda Kanmaz, Özlem Hergüler
article en
3 citations

Abstract

Nusinersen treatment initiated before 12 months of age, especially before 3 months of age, yielded the most favorable motor outcomes in patients with SMA type 1. Early initiation is associated with improved motor milestones and reduced need for ventilatory support. However, no significant improvements were observed in the bulbar function or in patients requiring extensive respiratory support.

Frontiers in NeurologyVol. 16
Ankara University (TR), Karadeniz Technical University (TR), Dokuz Eylül University (TR), Akdeniz University (TR), Inonu University (TR), Ondokuz Mayıs University (TR), Ege University (TR), Directorate of Health (IS), Necmettin Erbakan University (TR), Istanbul University-Cerrahpaşa (TR), Sağlık Bilimleri Üniversitesi (TR), Lokman Hekim Üniversitesi (TR), Eskişehir Osmangazi University (TR), Mersin Üniversitesi (TR), Kocaeli Üniversitesi (TR), Cukurova University (TR), Gaziantep University (TR), Atatürk University (TR), Istanbul University (TR), Marmara University (TR), Erciyes University (TR), Pharmaceuticals and Medical Devices Agency (JP), Gazi University (TR)
Good health and well-being
Openalex Percentile: Top 6%
Neurogenetic and Muscular Disorders Research
4.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.